Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma
Apoptosis · 2024
DOI: 10.1007/s10495-024-02011-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Kang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, Foshan, …. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Colonic Neoplasms, Tumor Microenvironment, Adenocarcinoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Guangdong Province, China, the 2021 Special Innovation Project of Department of Education of Guangdong Province, Foshan City's 13th Five-Year Key Specialty Project.
Abstract (Originalsprache)
This study aims to investigate the role and prognostic significance of long non-coding RNAs (lncRNAs) associated with disulfidptosis in colon adenocarcinoma (COAD). The TCGA database’s clinical data and transcriptome profiles were employed. Analysis of previous studies identified 10 disulfidptosis-related genes (DRGs). We used these genes to construct a signature that could independently and accurately predict the prognosis of patients with COAD. The Kaplan-Meier (K-M) curve analysis showed that the lower-risk group had a better prognosis. With the help of multivariate Cox regression analysis, the risk score produced from the patient’s signature might independently predict the outcomes. Utilizing a nomogram, the receiver operating characteristic (ROC) curve, and principal component analysis (PCA), the signature’s predictive ability was also confirmed. It’s interesting to note that immunotherapy, especially PD-1 immune checkpoint suppression, was more likely to benefit low-risk patients. The IC50 levels for certain anticancer agents were lower in the high-risk group. Finally, qRT-PCR analyses in colon cancer cell lines revealed elevated levels of lncRNAs CASC9, ZEB1-AS1, ATP2A1-AS1, SNHG7, AL683813.1, and AP003555.1, and reduced levels of FAM160A1-DT and AC112220.2, compared to normal cell lines. This signature offers insights into prognosis, tumor microenvironment, and options for immunotherapy and antitumor drugs in patients with COAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, Foshan, Guangdong Province, 528300, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.
- Guangdong Medical University, Zhanjiang, Dongguan, 523808, China. veryan0532@163.com.
- GCP Center, Shunde Hospital, Southern Medical University, The First People's Hospital of Shunde Foshan), Foshan, Guangdong, 528300, China. veryan0532@163.com.
- Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Shunde, Foshan, Guangdong Province, 528300, China. doctorken@smu.edu.cn.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510080, China. doctorken@smu.edu.cn.
Förderung
- the Natural Science Foundation of Guangdong Province, China
- the 2021 Special Innovation Project of Department of Education of Guangdong Province
- Foshan City's 13th Five-Year Key Specialty Project
- Scientific Research Start Plan of Shunde Hospital, Southern Medical University
- Foshan City’s 13th Five-Year Key Specialty Project
Zitieren
APA
Wang, K., Yu, J., Xu, Q., Peng, Y., Li, H., Lu, Y., & Ouyang, M. (2024). Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis. https://doi.org/10.1007/s10495-024-02011-x
Vancouver
Wang K, Yu J, Xu Q, Peng Y, Li H, Lu Y, et al. Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma. Apoptosis. 2024. doi:10.1007/s10495-024-02011-x
BibTeX
@article{Wang2024,
author = {Wang, Kang and Yu, Jing and Xu, Qihuan and Peng, Yuanhong and Li, Haibin and Lu, Yan and Ouyang, Manzhao},
title = {Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma},
journal = {Apoptosis},
year = {2024},
doi = {10.1007/s10495-024-02011-x}
}
EUVIMED